Ethics and Ethical Standards for Pharmacists for Pharmacists facing an Ahpra notification, complaint or allegation

The reasoning: which principles were engaged, where they conflicted, which prevailed and why — whether you queried, who you contacted and what you were told — and what you would weigh differently now, with the clause of the shared Code of conduct you fell short of named by you, before the Board names it. The course’s reflective practice lesson lists what a high-quality statement contains: a factual description, an analysis of the contributing factors, the ethical principles and professional standards involved, what you learned, and a concrete plan for improvement. It names Gibbs’ Reflective Cycle, Driscoll’s “What? So what? Now what?” and Borton’s framework as models, and warns that a vague or formulaic statement is unlikely to satisfy the Board.

Yes — before anything is written to Ahpra, the Pharmacy Board, a panel, a tribunal, your employer or a health complaints body. Your indemnity insurer (PDL or another), the PSA, the Pharmacy Guild or your association, or a lawyer should read a response before it goes. Nothing on this page is legal advice, and no course determines the outcome of a notification.

No provider is accredited by Ahpra or any National Board, and no course decides a matter. What the Board, a panel and a tribunal weigh is dated, targeted remediation with reflection that engages the standard — and this course works through the shared Code of conduct topic by topic, from communication and boundaries to errors, disclosure and advertising, so the connection is plain on the certificate and in your reflective account. Check the wording of any condition, undertaking or direction with your indemnity insurer (PDL or another), the PSA, the Pharmacy Guild or your association or a lawyer before you rely on it.

After an assessment or an investigation the Pharmacy Board may take no further action, caution you, accept an undertaking or impose conditions on your registration (section 178), refer you to a panel, or refer the most serious matters to a tribunal (section 193), which can reprimand, impose conditions, fine, suspend, cancel registration and disqualify (section 196). The course describes the process — assessment, investigation, outcome — and shows why pharmacists who show insight, take responsibility and engage in remediation are treated differently from those who deflect blame or repeat the behaviour.

Not Ahpra, in either case. In New South Wales the Pharmacy Council of NSW and the Health Care Complaints Commission manage conduct, health and performance matters between them, and Ahpra does not investigate registered practitioners there. In Queensland every complaint goes first to the Office of the Health Ombudsman, which decides what it keeps and what it refers on to Ahpra and the Board. A supply matter may also involve your state or territory medicines and poisons regulator separately. The letterhead tells you which body has your file, and the same response — the reasoning, the standard, the remediation — is what each of them reads for.

Refusing supply where safety concerns exist is part of ethical practice, and the course says so directly. A complaint that follows a refusal can be less about the clinical point than about how it was explained — whether the patient felt judged, or was left with no route forward. Clause 3.2 requires courteous, respectful and honest communication and that you confirm the patient understood; a refusal that was clinically right and communicated badly is still a notification. The response names the concern, the explanation given and the alternative offered.

Clarifying an ambiguous or contraindicated prescription with the prescriber is your own obligation under clause 5.4, not a courtesy. What is examined is whether you had the doubt, what you did about it, who you contacted, what you were told, and whether any of that is documented. Dispensing against your own unresolved doubt with nothing written down is the difficult position; the course’s beneficence lesson names clarifying an ambiguous prescription with the prescriber as part of medicines management, its record-keeping lesson counts clinical interventions among what is documented, and its insight and reflection lessons set out what a credible response contains.

No. The Pharmacy Board and Ahpra deal with your registration and your conduct against the code. Your state or territory medicines and poisons regulator deals with the legislation governing supply. They are different bodies with different powers and different timetables, they can run at once, a finding in one does not decide the other, and something said to one may be seen by the other. That is a specific reason to take advice before responding to either; the same response — the reasoning, the standard, the remediation — is what the Board reads for.

It depends entirely on how. A clearly dated later entry made to protocol is ordinary practice. Altering or omitting the original after an error has occurred is record falsification, and it converts a dispensing matter into a probity one, which is assessed more seriously because it goes to whether you can be relied on. Say what was changed, when and why, and take advice before writing anything further.

It is context, not an answer. The course names commercial pressure among the causes of ethical breach and warns against commercial motivations that conflict with patient welfare. Clause 8.10 requires that a commercial interest does not affect how patients are treated, and clause 1.3 prohibits providing unnecessary services. If targets are shaping recommendations, raising it formally and recording that you did is the professional response, and a response that shows you did is read as insight.

Yes. Clause 4.2 applies to every service you provide, not only to dispensing: provide information the patient can understand, allow time for questions, include the material risks and expected outcomes, and obtain agreement. The course names failing to obtain informed consent for services or vaccinations among the common ethical breaches, and applies informed decision-making to over-the-counter sales, pharmacist-only medicines, vaccination services and medication reviews alike; a routine service is the one it is easy to treat as though consent were implied.

This course is about the reasoning behind a decision and the ethical breaches a notification names; the Professionalism course is about conduct — communication, records, social media, scope and impairment as behaviour, measured against the conduct clauses of the code. A notification that says a decision or a relationship was unethical usually starts here; one that describes how you behaved usually starts there. The two are often taken together.

The Pharmacy Board of Australia sets its own continuing professional development registration standard, and targeted CPD on the subject of a notification is among the remediation the Board and the tribunals recognise. The certificate records the course, the 2 CPD hours and the date, which is what a CPD portfolio needs; how the hours count towards your requirement depends on the standard’s categories, so check them.

The course is 2 CPD hours, self-paced, with twelve months’ access from purchase. The certificate is issued on completion, dated, with the course title and the CPD hours, for a response, a portfolio or your CPD record.